EP3256009B1 - Reduktion der konzentration von gramnegativen bakterien in einem fermentierten lebensmittelprodukt durch kombination von rotweinextrakt und einer kultur mit mindestens einem bakteriocin-produzierenden milchsäurebakterienstamm - Google Patents

Reduktion der konzentration von gramnegativen bakterien in einem fermentierten lebensmittelprodukt durch kombination von rotweinextrakt und einer kultur mit mindestens einem bakteriocin-produzierenden milchsäurebakterienstamm Download PDF

Info

Publication number
EP3256009B1
EP3256009B1 EP16704594.7A EP16704594A EP3256009B1 EP 3256009 B1 EP3256009 B1 EP 3256009B1 EP 16704594 A EP16704594 A EP 16704594A EP 3256009 B1 EP3256009 B1 EP 3256009B1
Authority
EP
European Patent Office
Prior art keywords
culture
red wine
gram
bacteriocin
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP16704594.7A
Other languages
English (en)
French (fr)
Other versions
EP3256009A1 (de
Inventor
Michael ERKES
Tim Martin SEIBERT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chr Hansen AS
Original Assignee
Chr Hansen AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chr Hansen AS filed Critical Chr Hansen AS
Priority to PL16704594T priority Critical patent/PL3256009T3/pl
Publication of EP3256009A1 publication Critical patent/EP3256009A1/de
Application granted granted Critical
Publication of EP3256009B1 publication Critical patent/EP3256009B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B4/00—General methods for preserving meat, sausages, fish or fish products
    • A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
    • A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
    • A23B4/20—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B4/00—General methods for preserving meat, sausages, fish or fish products
    • A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
    • A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
    • A23B4/20—Organic compounds; Microorganisms; Enzymes
    • A23B4/22—Microorganisms; Enzymes; Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/34635—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3472—Compounds of undetermined constitution obtained from animals or plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3571—Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/133—Curvatus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/41—Pediococcus
    • A23V2400/413—Acidilactici

Definitions

  • Bacterial contamination of food products is known to be responsible for the transmission of food borne illness. This problem is particularly important in meat and dairy products which are not reheated by consumers prior to ingestion and which are stored for extended times in refrigerators at 2-10°C. Pathogenic Gram-negative bacteria such as Salmonella and E. coli are of particular concern in food products.
  • the present invention is based upon the surprising finding by the present inventors in a Salmonella challenge test that the combination of red wine extract and a bacteriocin-producing culture is able to inhibit and even eliminate Salmonella already present to a level below the qualitative detection limit whereas the application of the bacteriocin-producing culture alone, without the red wine extract, did not lead to the same effect. Based upon this surprising finding it is contemplated that the combination of red wine extract with a culture comprising at least one bacteriocin-producing lactic acid bacterial strain will be useful also against other Gram-negative bacteria and in other fermented food products, e.g. fermented dairy products.
  • the present invention relates to the use of red wine extract produced from red wine by dealcoholization, concentration and drying, and a culture comprising at least one class IIa bacteriocin-producing lactic acid bacterial strain for reducing the concentration of Gram-negative bacteria in food products kept at a temperature of at the most 15oC.
  • Teewurst is a traditional sausage in Germany, typically made from pork and beef, which is characterized by a soft and spreadable texture. Teewurst can be grouped together with products like "fharide Mettwurst" which show a relatively high pH compared to other fermented sausages and which are less dried, showing a relatively high water content. The preparation and processing of this product does not include any heat treatment or the use of safety hurdles other than the use of salt, nitrate/nitrite salts and, as the case may be, smoking. Due to the slow acidification, the high water activity and the lack of other putative hurdles, Teewurst is a product with a certain risk for microbiological contamination.
  • Salmonella is a serious problem for spreadable meat products like Teewurst as Salmonella is most efficiently inhibited by a fast drop in pH which is not wanted for spreadable sausages.
  • no efficient anti -Salmonella solution is commercially available for raw fermented food applications.
  • CN102188034 A (UNIV TIANJIN SCIENCE & TECH), 2011-09-21, WPI/Thomson AN 2011-N2883 (XP002703338) discloses a composite biopreservative antistaling agent useful for preserving foodstuffs, comprising nisin, natamycin, B. subtilis and resveratrol.
  • the present invention relates to a method of reducing the concentration of Gram-negative bacteria in a fermented food product, the method comprising adding a red wine extract produced from red wine by dealcoholization, concentration and drying, and a culture comprising at least one class IIa bacteriocin-producing lactic acid bacterial strain to a food product, ripening the food product, and storing the food product at a temperature of at the most 15°C until a concentration of less than 1 E-1 of Gram-negative bacteria.
  • a solution for the reduction of Gram-negative bacteria such as Salmonella and E. coli is of great interest in fermented food products, in particular raw meat applications such as spreadable meat products like "Teewurst” and sliceable meat products such as sausages, e.g. salami.
  • lactic acid bacteria to induce fermentation of food products, typically raw salted meat products, for providing the desired change in the characteristics of the food matrix during fermentation (e.g. a desired acidification, and certain other sensory and technological parameters).
  • the lactic acid bacteria primarily produce lactic acid whereby pH drops to the desired pH-value depending on the strain(s) and the processing conditions (temperature, sugar type/content etc.), and importantly, the sensory properties of the product are distinctly changed.
  • food product refers to any food that is susceptible to bacterial growth and proliferation of pathogenic bacteria.
  • Such food products include, but are not limited to, meat, dairy products, vegetables, fruits and grains.
  • the term "meat” refers to any meat product or meat by-product (including those processed) from an animal which is consumed by humans or animals, including, without limitation, meat from bovine, ovine, porcine, poultry, fish and crustaceous seafood.
  • fermented meat products are sausages e.g. spreadable and dried sausages, ham, and fermented fish.
  • dairy product is intended to include any food product made using milk or milk products, including, but not limited to, milk, yogurt, ice cream, cheese, butter, and cream.
  • fertilization refers to the process of biochemical changes e.g. an acidification in animal and/or plant material (i.e. a food matrix), involving activity of live microbial cells under aerobic and/or anaerobic conditions to obtain a food product of desired quality.
  • animal and/or plant material i.e. a food matrix
  • ripening refers to the maturation, drying, flavor development, enzymatic activity like lipolysis or proteolysis leading to complex flavor development in particular for longer ripened products like salami.
  • Micrococcaceae spp. and Staphylococcaceae spp. which are often also added are responsible for enhancing the flavor formation by producing non-volatile and volatile compounds through various biochemical reaction steps. Additionally, the Micrococcaceae spp. and Streptococcaceae spp. are responsible for the speed and intensity of color formation in particular in fermented sausage types.
  • Lactic acid bacterial strain(s) added to food to inhibit pathogens and/or extend shelf life without changing the sensory properties of the product are termed "protective cultures”.
  • Protective cultures are not intended to change the sensory properties of the product.
  • Their use or that of their metabolic products is often referred to as “biopreservation” or “bioprotection”.
  • a strain as a bioprotective culture is the ability of the strain to work in the food product for which it is intended. In this respect it is not only important that the strain is able to inhibit any undesired food-borne pathogenic bacteria in the product under relevant storage conditions, but also that it does not produce any undesired sensory effects (off-taste, off-odors or unwanted color changes).
  • red wine extract refers to a powder produced from red wine essentially by dealcoholization, concentration, and drying.
  • further steps are filtration and pasteurization.
  • dealcoholization can be achieved by separation techniques or a combination of techniques like partial vacuum evaporation, membrane techniques or distillation.
  • the drying is preferably performed by spray drying which is a drying technique that uses hot air to transfer the heat and remove evaporated water by an apparatus which allows the formation of particles from dispersion.
  • Alternative but more costly drying methods are vacuum drying and freeze drying.
  • Pasteurization is a sterilization technique commonly used for different foods where the food source is heated to temperatures between 60°C-90°C for a very short time. The short time interval during which the food material is heated guarantees that only minor thermic changes take place in regard to flavor, texture etc..
  • red wine powder which comprises all components commonly found in red wine except for water and alcohol.
  • bacteriocins A great number of Gram-positive and Gram-negative bacteria produce during their growth proteinaceous substances which possess antimicrobial activities. When being produced by Gram-positive bacteria these substances are called bacteriocins. Due to their high importance in the food industry the lactic acid bacteria are the most intensively studied group of bacteriocin-producing Gram-positive bacteria. However, most of the bacteriocins produced by lactic acid bacteria are not active towards Gram-negative bacteria. This is also the case for the bacteriocins produced by the strains used in the culture in the examples of the present application. It is contemplated that the reason that the bacteriocins are not active towards Gram-negative bacteria is the additional layer that is surrounding the cell wall of Gram-negative bacteria, the outer membrane (OM).
  • OM outer membrane
  • this additional outer membrane layer serves as a selective permeation barrier to prevent the entry of bactericidal respectively toxic agents while at the same time allowing the influx of nutritional components. Due to its polyanionic character, the OM cannot be passed by most bactericidal agents like antibiotics, bacteriocins or lytic proteins (e.g. lysozyme).
  • the inhibitory activity of the combination of red wine extract produced from red wine by dealcoholization, concentration and drying, and a culture comprising at least one class IIa bacteriocin-producing lactic acid bacterial strain may be based on a mechanism where components of the red wine extract serve as OM-permeabilizing agents.
  • the present invention provides a method for reducing the concentration of Gram-negative bacteria in a fermented food product.
  • the term "reducing the concentration” relates to a reduction in the amount of pathogenic bacteria.
  • a reduction may be provided by killing, inactivating or inhibiting the growth of the pathogenic bacteria.
  • the log loss of pathogenic bacteria during the storage is at least 1 after 3 weeks of storage at 15°C, preferably at least 2, more preferably at least 3, even more preferably at least 4, most preferably at least 5.
  • the log loss may increase over time and the log loss is preferably at least 2, more preferably at least 3, even more preferably at least 4, most preferably at least 5 after 4 or 5 weeks of storage at 15°C.
  • the log loss depends inter alia on the amount of pathogenic bacteria originally present in the product, the higher the amount the higher the potential log loss. As evident from figure 2 , the reduction may lead to the amount being below the qualitative detection limit. In a preferred embodiment, Gram-negative bacteria already present are eliminated or reduced to an amount being below the qualitative detection limit.
  • a significant concern in the food processing industry is controlling the growth of food-borne Gram-negative bacteria capable of causing disease or illness in animals or humans either by themselves or by toxins that cause disease or illness.
  • Examples of food-borne Gram-negative bacteria are Aeromonas caviae; Aeromonas hydrophila; Aeromonas sobria; Campylobacter jejuni; Citrobacter ssp.; Enterobacter ssp.; Escherichia coli enteroinvasive strains; Escherichia coli enteropathogenic strains; Escherichia coli enterotoxigenic strains; Escherichia coli O157: H7; Klebsiella ssp.; Plesiomonas shigelloides; Salmonella ssp.; Shigella ssp.; Vibrio cholerae; Yersinia enterocolitica.
  • the pathogenic bacteria to be reduced according to the present invention are E. coli and Salmonella spp..
  • the present invention is based on an experiment demonstrating reduction of the concentration of Gram-negative bacteria in a fermented food product by the combination of a red wine extract produced from red wine extract by dealcoholization, concentration and drying with a culture comprising at least one class IIa bacteriocin-producing lactic acid bacterial strain.
  • the effect of the above mentioned combination has been demonstrated by preparing a standard meat mince of a "grobe Teewurst" by applying Staphylococcus xylosus (DSM 28308), Lactobacillus curvatus (DSM 18775) and Pediococcus acidilactici (DSM 28307).
  • the meat mince was inoculated by three different S. typhimurium strains at appropriate facilities.
  • the prepared meat mince was filled into standard casings and ripened for three days, followed by a period of storage at a temperature of at the most 15°C.
  • the temperature should be appropriate to ensure production of class IIa bacteriocin by the bacteriocin-producing strain or strains. In some embodiments, the temperature is in the range of 2 to 10°C.
  • the food product may be packaged under vacuum or at modified atmosphere, if desired.
  • shelf life means the period of time that a food product remains saleable to retail customers.
  • shelf life of meat and meat by-products is about 30 to 40 days after an animal has been slaughtered. Refrigeration of meat during this period of time is expected to largely arrest and/or retard the growth of pathogenic bacteria, and to a lesser extent, spoilage bacteria. After about 30 to 40 days, however, refrigeration is no longer able to effectively control the proliferation of spoilage bacteria below acceptable levels.
  • sausages were analyzed in regard to the cell count of S. typhimurium. As can be seen from figure 2 , both lines pass the quantitative detection threshold, 1E+ 1 cfu/g, at day 10 and the black line passes the qualitative detection threshold ⁇ 4E-2 cfu/g or negative in 25g on day 24, the result being 3E-2 cfu/g. From day 24 until the end of shelf life S. typhimurium could not be detected anymore in sausages produced by the combination of red wine extract produced from red wine by dealcoholization, concentration and drying with a culture comprising at least one class IIa bacteriocin-producing strain, whereas Salmonella was still present in sausages produced with the culture with the at least one class IIa bacteriocin-producing strain only.
  • the effect of the described combination of red wine extract produced from red wine by dealcoholization, concentration and drying, and culture comprising at least one class IIa bacteriocin-producing strain is rather based on the disruption of the integrity of the outer membrane of the Gram-negative bacteria, such as Salmonella, by components of the red wine extract.
  • the disturbance of the outer membrane integrity allows the antimicrobial peptides (bacteriocins) produced by the bacteriocin-producing strain(s) of the culture to enter their target.
  • bacteriocin-producing lactic acid bacterial strain a strain producing a proteinaceous compound which shows a bactericidal effect towards other strains of the same or closely related species.
  • the bacteriocin-producing strain is not itself inhibited by the bacteriocin it produces.
  • the different bacteriocins produced by a wide variety of strains are rather heterogenous and are classified mostly based on their molecular weight.
  • the inhibitory spectrum of the bacteriocin-producing culture respectively strain can be narrow but can also be relatively broad, meaning that the produced bacteriocin can be inhibiting also different bacterial species.
  • the bacteriocin-producing strain produces a class IIa bacteriocin such as pediocin, bavaracin, sakacin, curvacin, leucosin, plantaricin.
  • the bioprotective strains Lactobacillus curvatus and Pediococcus acidilactici tested herein are both producing a class IIa bacteriocin.
  • bacteriocin activity test For a bacteriocin IIa activity the strain could be tested as outlined in example 2.
  • the cell free supernatant of the bacteriocin-producing strain should at least cause a 50% growth inhibition in regard to optical density OD600 of a suitable indicator strain with a dilution factor not less than 0.5 equal to 40 AU/ml.
  • any bacterial strain producing a class IIa bacteriocin will be able to reduce the concentration of Gram-negative bacteria such as Salmonella when combined with red wine extract.
  • bacteria producing class IIa bacteriocins are Carnobacterium maltaromaticum, Carnobacterium pisicola, Carnobacterium divergens, Lactobacillus curvatus, Lactobacillus sakei, Lactobacillus plantarum, Lactococcus lactis, Leuconostoc carnosum, Leuconostoc gelidium, Pediococcus acidilactici, Pediococcus pentosaceus. Examples of such strains can be found in Eijsink et al., 1998, Ennahar et al., 2000, and Vermeiren et al., 2004.
  • Presently preferred strains are the Lactobacillus curvatus strain deposited as DSM 18775 and the Pediococcus acidilactici strain deposited as DSM 28307.
  • a culture comprising at least two class IIa bacteriocin-producing strains. If more than one strain is used, the strains preferably produce different class IIa bacteriocin(s) and/or act on different targets.
  • the culture comprises both the Lactobacillus curvatus strain deposited as DSM 18775 and the Pediococcus acidilactici strain deposited as DSM 28307.
  • the culture may comprise at least three class IIa bacteriocin-producing strains.
  • the culture comprises four or more class IIa bacteriocin-producing strains.
  • one of them will be the Lactobacillus curvatus strain deposited as DSM 18775 and the Pediococcus acidilactici strain deposited as DSM 28307, or both.
  • the culture may in addition to the at least one class IIa bacteriocin-producing lactic acid bacterial strain comprise at least one ripening strain which assists at the least one class IIa bacteriocin-producing lactic acid bacterial strain in the development of quality parameters such as acidification, reduction in water binding and water activity, general appearance, color, texture, odor, aroma, taste, flavor and other sensorial and technological parameters.
  • ripening strains are Staphylococcus carnosus and Staphylococcus xylosus, i.e. the Staphylococcus xylosus deposited as DSM 28308.
  • the class IIa bacteriocin-producing lactic acid bacterial strain(s) only are contemplated to be sufficient to produce an appropriate fermented meat product as also class IIa bacteriocin-producing strains are contributing to taste.
  • at least one Staphylococcus or Micrococcaceae strain could be added for taste and coloring reasons as these strains are able to reduce the nitrate to nitrite which is further reacting to NO which in the end reacts with the myoglobin in the meat to a stable red nitrosylmyoglobin.
  • the fermented food product is manufactured by providing a food matrix, adding a red wine extract produced from red wine by dealcoholization, concentration and drying, and a culture comprising at least one class IIa bacteriocin-producing lactic acid bacterial strain, ripening the product, optionally drying the food product, and storing the food product at a temperature of at the most 15°C until a concentration of less than 1 E-1 of Gram-negative bacteria.
  • the present invention will be useful for all fermented food products but particularly useful for meat products having an a w in the range of 0.92 to 0.96, such as in the range of 0.92 to 0.93, 0.93 to 0.94, 0.94 to 0.95 or 0.95 to 0.96.
  • the food product has a salt content (w/w) in the range of 2.4% to 4.0%, such as 2.4% to 3.0%, 3.0% to 3.5%, or 3.5% to 4.0%, and a short ripening in the range of 2 to 16 days, such as 2 to 9 days, or 10 to 16 days.
  • the pH is preferably in the range of 4.5 to 6.0.
  • Examples of such products are spreadable products such as spreadable sausages which generally have a pH in the range of from 5.3 to 6.0, such as 5.3 to 5.7 or 5.8 to 6.0, and dried meat products such as sliceable sausages generally having a pH in the range of 4.5 to less than 5.3, such as 4.5 to 4.8 or 4.9 to less than 5.3. From a safety point of view, a low pH, a low a w , and a high salt content is preferred but this is not always feasible in order to obtain the desired sensory effects of the product.
  • Spreadable sausages are made by grinding of fat tissue and the originating fat is encasing the meat particles. This is leading to spreadability which is most distinctive in case of finely grinded products.
  • the sausage is ripened depending on the different sausage type, cured, slightly dried and not intended for long storage.
  • Examples of spreadable sausage products are: Teewurst, Teewurst Studgenwalder Art, grosse Teewurst, Mettwurst, Streichmettwurst, Hofer Rindfleischwurst, Braunschweiger Mettwurst, Braunschweiger Pfeffersburgchen, Zwiebelmettwurst, Zwiebelwurst, Frische Mettwurst, Vesperwurst, practicesswurst, Schmierwurst and fette Mettwurst.
  • Dried sausages are essentially made in a similar manner but subjected to a longer ripening period of 10 to 16 days such that a lower pH of less than 5.3 is reached and more drying to an a w in the range of 0.92 to 0.94.
  • sliceable sausage products are Salami, Katenrauchwurst, Mettwurst, Cervelatwurst, Lucasgetrocknete Mettwurst, Plockwurst, Räucherenden, Kabanossi, Landjäger, Pepperoni and others.
  • the expression "effective amount” refers to the amount of class IIa bacteriocin-producing lactic acid bacteria which give rise to an inhibition of the bacterial growth or a reduction of the number of pathogenic bacteria from the food product.
  • the culture comprising at least one bacteriocin-producing lactic acid bacterial strain is added during the cutter process with spices prior to the addition of salt.
  • the culture is added in a concentration in the range of 1E+ 4 - 1E+ 10 cfu/g product, such as in the range of 1E+ 5 - 1E+ 9 cfu/g product, e.g. in the range of 1E+ 6 - 1E+ 8 cfu/g product.
  • the culture is added in a range of 1E+ 6 to 1E+ 8 cfu/g product such as 1E+ 7 cfu/g product. If the culture comprises more than one class IIa bacteriocin-producing strain, these numbers refer to each strain.
  • the invention may be provided as a kit for reducing the concentration of Gram-negative bacteria in a food product comprising a red wine extract produced from red wine by dealcoholization, concentration and drying, and a culture comprising at least one class IIa bacteriocin-producing culture.
  • the culture comprising at least one class IIa bacteriocin-producing lactic acid bacterial strain is provided in a suitable package.
  • a suitable package may be e.g. a pouch, a tetra-pak, a can and any other suitable means described in the art for containing microbial species.
  • the culture comprising at least one class IIa bacteriocin-producing lactic acid bacterial strain may be provided in any suitable form e.g. in a frozen or freeze dried form.
  • the kit will also comprise red wine extract produced from red wine by dealcoholization, concentration and drying either as a separate package or in a mixture with the culture.
  • the kit may further comprise instructions as to how to use the kit for reducing the concentration of Gram-negative bacteria in a food product.
  • Lactobacillus curvatus strain CHCC9720 has been deposited at DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Inhoffenstrasse 7B, D-38124 Braunschweig) under the accession number DSM 18775 with a deposit date of November 9, 2006 by Chr. Hansen A/S, Denmark. The deposit has been made under the conditions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure.
  • the Pediococcus acidilactici CHCC4073 has been deposited at DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Inhoffenstrasse 7B, D-38124 Braunschweig) under the accession number DSM 28307 with a deposit date of January 30, 2014 by Chr. Hansen A/S, Denmark. The deposit has been made under the conditions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure.
  • the Staphylococcus xylosus strain CHCC5680 has been deposited at DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Inhoffenstrasse 7B, D-38124 Braunschweig) under the accession number DSM 28308 with a deposit date of January 30, 2014 by Chr. Hansen A/S, Denmark. The deposit has been made under the conditions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure.
  • Example 1 Salmonella challenge test
  • a standard meat mince for grobe Teewurst was supplemented with Staphylococcus xylosus (DSM 28308), Lactobacillus curvatus (DSM 18775) and Pediococcus acidilactici (DSM 28307) with a cell count concentration in a range of 1.0E+ 6 cfu/g to 1.0E+ 7 cfu/g of meat for each strain.
  • the meat mince was subsequently inoculated by 5.0E+ 01 cfu/g of three different S. enterica subsp. typhimurium strains (DSM554), a wild isolate from raw fermented sausage and a wild isolate from fresh pork meat (strains TZL-038 and TZL-039 from the strain collection of TZL-MiTec GmbH) (Technologietransfer Zentrum Lippe).
  • DSM554 S. enterica subsp. typhimurium strains
  • strains TZL-038 and TZL-039 from the strain collection of TZL-MiTec GmbH
  • the prepared meat mince was divided into 2 batches. Into one of the batches 5 g/kg of red wine extract (697808 Red Wine Extract powder) commercially available from Chr. Hansen A/S was added. To the control batch no red wine extract was added. Both batches of meat mince were filled into standard casings with a diameter of 50 mm and a length of 230 mm with a target filling weight of approx. 285 g.
  • Figure 2 shows the development of the Salmonella cell count for both the control batch where only the bacteriocin-producing culture was added and the sample batch where the red wine extract was added additionally. As evident from the figure there is a clear reduction of the cell count of Salmonella when adding red wine extract in addition to the bacteriocin-producing culture compared to the control batch without the addition of red wine extract. From day 24 all samples (25 g) were negative for Salmonella when using the combination of bacteriocin-producing culture and red wine extract.
  • Figure 2 illustrates that from day 24 until the end of shelf life S. typhimurium could not be detected anymore in sausages produced by the combination of red wine extract with the culture comprising Staphylococcus xylosus (DSM 28308), Lactobacillus curvatus (DSM 18775) and Pediococcus acidilactici (DSM 28307) whereas Salmonella was still present in sausages produced with the culture only.
  • DSM 28308 Staphylococcus xylosus
  • DSM 18775 Lactobacillus curvatus
  • DSM 28307 Pediococcus acidilactici
  • the aim of this test is to quantitatively determ ine the activity of group IIa bacteriocins produced by a culture comprising at least one bacteriocin-producing lactic acid bacterial strain by using a rapid microtiter assay which is a modification and combination of the assays described by Budde et al., 2003.
  • group IIa bacteriocins inhibit Lactobacillus sakei NCFB 2714, hence this strain is often used as indicator organism in assays for detection of class IIa bacteriocins.
  • the present microtiter assay gives a quantitative measure of the bacteriocin activity of class IIa bacteriocins expressed as Arbitrary Units (AU/ml) based on the number of two-fold dilutions of a culture supernatant causing 50% growth inhibition of the indicator organism Lactobacillus sakei NCFB 2714.
  • the culture fermentate of a culture comprising at least one lactic acid bacterial strain putatively producing a bacteriocin is prepared by inoculating MRS broth with the bacteriocin-producing strain or culture to be tested to reach an OD 600 of 0.01- 0.02 (OD 600 after subtraction of the blank value i.e. non inoculated MRS) which corresponds to a cell concentration of about 1E+ 07 cfu/ml.
  • the culture is inoculated overnight (about 18h) at 30°C.
  • the cell suspension is centrifuged at 4500 g for 15 min at 5°C.
  • the supernatant is removed and adjusted to pH 6.0 ⁇ 0.1 by using NaOH or 0.2N HCL followed by filter sterilization (0.2 ⁇ m).
  • the microtiter assay is prepared by first preparing the indicator solution strain by diluting 0.2 mL of the Lactobacillus sakei NCFB 2714 strain in 18 mL MRS broth. In each well 50 ⁇ l MRS-broth is added except for the first well of each row and the wells from the rows G and H and 50 ⁇ l of supernatant is added to the first and the second wells of the two first rows. From the well of the second row, 50 ⁇ l is transferred to the next well and this step is repeated. The content of each well has to be thoroughly mixed with the pipette before transferring liquid to the next well. Then 150 ⁇ l of the indicator strain is added to each well except row H (the blank). 10 ⁇ l of proteinase K is added in each well of row G. The microtiterplate is read in the microreader by measuring the OD 600 every 30 min during 20 hours at 30°C.
  • the OD 600 (0h) is subtracted from The OD 600 (20h).
  • the activity of class IIa bacteriocins is reported in Arbitrary Units (AU/ml) defined as the reciprocal of the highest two-fold dilution showing 50% growth inhibition, calculated as 50% of the turbidity obtained for the indicator organism in the absence of bacteriocin solution.
  • DSM11320 was tested in a challenge test performed in a meat model system based on a traditional "Teewurst" formulation. DSM11320 is a non-pathogenic S.
  • enterica strain which is classified as risk class I according to TRBA 466 ("Technische calculating für biologische Hästoffe” - “Einstufung von Prokaryonten (Bacteria und Archaea) in cuisine weakness”).
  • TRBA 466 Technische calculating für biologische Hästoffe
  • the challenge test was performed according to the following description at appropriate facilities.
  • a standard meat mince for "feine Teewurst” was produced according to the production process described (see table 4) and supplemented with dextrose (C* PharmDex 02010, Cargill GmbH, Cerestarstrasse 2, D-47809 Krefeld) and RWE (697808 Red Wine Extract powder) and the cultures T-D-66 ( Lactobacillus plantarum, and Staphylococcus carnosus ) or B-LC-20 ( Pediococcus acidilactici ) and F-LC ( Staphylococcus xylosus, Pediococcus acidilactici, and Lactobacillus curvatus ) according to the batch description (see table 5).
  • the applied cultures are commercially available from Chr. Hansen A/S and were dosed according to the standard recommendation of Chr. Hansen.
  • the batches 1-6 were subsequently inoculated with S . enterica serovar Typhimurium DSM11320 with a target cell count of 1.0E+ 5 cfu/g of meat.
  • the prepared beakers were fermented and ripened according to the temperature profile shown in figure 3 mimicking a standard process for the production of "Teewurst".
  • the meat model system was not subjected to a drying procedure.
  • the development of pH is shown in figure 3 .
  • the pH of the different batches was determined during the first 100 hours of the process by continuous measurement. In the following the pH was only measured after 124 h, 268 h, 436 h and 916 h in 3 beakers per batch by 3 individual measurements for each.
  • Figure 4 shows the development of the Salmonella spp. cell count for the relevant batches. As evident from the figure there is a clear reduction of the cell count of Salmonella spp. when adding red wine extract (RWE) in addition to the class IIa bacteriocin-producing cultures B-LC-20 ( Pediococcus acidilactici ) and F-LC ( Staphylococcus xylosus, Pediococcus acidilactici, and Lactobacillus curvatus ) (batch 5 and 6) compared to the control batch 4 where only the class IIa bacteriocin-producing cultures and no RWE was added. The most significant reduction of Salmonella spp. can be seen for batch 5.
  • RWE red wine extract

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Claims (11)

  1. Verfahren zum Reduzieren der Konzentration von gramnegativen Bakterien in einem Lebensmittelprodukt, wobei das Verfahren Folgendes umfasst: Zugeben eines aus Rotwein durch Entalkoholisierung, Konzentration und Trocknung hergestellten Rotweinextrakts und einer Kultur, umfassend mindestens einen Bakteriocin der Klasse IIa produzierenden Milchsäurebakterienstamm, zu einem Lebensmittelprodukt, Reifenlassen des Lebensmittelprodukts und Lagern des Lebensmittelprodukts bei einer Temperatur von höchstens 15 °C bis zu einer Konzentration von weniger als 1 E-1 gramnegativer Bakterien.
  2. Verfahren nach Anspruch 1, wobei bereits vorhandene gramnegative Bakterien beseitigt werden.
  3. Verfahren nach Anspruch 1 oder 2, wobei die gramnegativen Bakterien aus Aeromonas caviae; Aeromonas hydrophila; Aeromonas sobria; Campylobacter jejuni; Citrobacter ssp.; Enterobacter ssp.; enteroinvasiven Escherichia coli-Stämmen; enteropathogenen Escherichia coli-Stämmen; enterotoxigenen Escherichia coli-Stämmen; Escherichia coli 0157:H7; Klebsiella ssp.; Plesiomonas shigelloides; Salmonella ssp.; Shigella ssp.; Vibrio cholerae; Yersinia enterocolitica ausgewählt werden.
  4. Verfahren nach einem der Ansprüche 1 bis 3, wobei die gramnegativen Bakterien Salmonella ssp. sind.
  5. Verfahren nach einem der Ansprüche 1 bis 4, wobei die Kultur mindestens einen Bakteriocin der Klasse IIa produzierenden Stamm, ausgewählt aus Carnobacterium mitarromaticum, Carnobacterium pisicola, Carnobacterium divergens, Lactobacillus curvatus, Lactobacillus plantarum, Lactobacillus sakei, Lactococcus lactis, Leuconostoc carnosum, Leuconostoc gelidium, Pediococcus acidilactici, Pediococcus pentosaceus, umfasst.
  6. Verfahren nach einem der Ansprüche 1 bis 5, wobei die Kultur mindestens eines von Lactobacillus curvatus DSM 18775 und Pediococcus acidilactici DSM 28307 umfasst.
  7. Verfahren nach einem der Ansprüche 1 bis 6, wobei das fermentierte Lebensmittelprodukt ein Milchprodukt, ein Fleischprodukt, ein Gemüseprodukt, Obst oder Getreide ist.
  8. Verfahren nach Anspruch 7, wobei das fermentierte Lebensmittelprodukt eine Streichwurst ist.
  9. Verfahren nach Anspruch 7, wobei das fermentierte Lebensmittelprodukt eine schneidbare Wurst ist.
  10. Kit zum Reduzieren der Konzentration von gramnegativen Bakterien in einem Lebensmittelprodukt, umfassend einen aus Rotwein durch Entalkoholisierung, Konzentration und Trocknung hergestellten Rotweinextrakt und eine Kultur, umfassend mindestens einen Bakteriocin der Klasse IIa produzierenden Milchsäurebakterienstamm.
  11. Verwendung von aus Rotwein durch Entalkoholisierung, Konzentration und Trocknung hergestelltem Rotweinextrakt und einer Kultur, umfassend mindestens einen Bakteriocin der Klasse IIa produzierenden Milchsäurebakterienstamm, zum Reduzieren der Konzentration von gramnegativen Bakterien in einem Lebensmittelprodukt, das bei einer Temperatur von höchstens 15 °C gehalten wird.
EP16704594.7A 2015-02-11 2016-02-11 Reduktion der konzentration von gramnegativen bakterien in einem fermentierten lebensmittelprodukt durch kombination von rotweinextrakt und einer kultur mit mindestens einem bakteriocin-produzierenden milchsäurebakterienstamm Active EP3256009B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL16704594T PL3256009T3 (pl) 2015-02-11 2016-02-11 Zmniejszanie stężenia bakterii gram-ujemnych w sfermentowanym produkcie spożywczym przy pomocy ekstraktu z czerwonego wina oraz kultury zawierającej co najmniej jeden szczep bakterii kwasu mlekowego wytwarzający bakteriocynę

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15154620 2015-02-11
PCT/EP2016/052899 WO2016128508A1 (en) 2015-02-11 2016-02-11 Reduction of the concentration of gram-negative bacteria in a fermented food product by the combination of red wine extract and a culture comprising at least one bacteriocin-producing lactic acid bacterial strain

Publications (2)

Publication Number Publication Date
EP3256009A1 EP3256009A1 (de) 2017-12-20
EP3256009B1 true EP3256009B1 (de) 2018-10-03

Family

ID=52472195

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16704594.7A Active EP3256009B1 (de) 2015-02-11 2016-02-11 Reduktion der konzentration von gramnegativen bakterien in einem fermentierten lebensmittelprodukt durch kombination von rotweinextrakt und einer kultur mit mindestens einem bakteriocin-produzierenden milchsäurebakterienstamm

Country Status (10)

Country Link
US (1) US10952448B2 (de)
EP (1) EP3256009B1 (de)
CN (1) CN107404913B (de)
AU (1) AU2016217830B2 (de)
CA (1) CA2976292C (de)
DK (1) DK3256009T3 (de)
ES (1) ES2702769T3 (de)
MX (1) MX2017010064A (de)
PL (1) PL3256009T3 (de)
WO (1) WO2016128508A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018322800A1 (en) 2017-08-31 2020-03-05 Chr. Hansen A/S New Lactobacillus curvatus strains useful for inhibition of Listeria
WO2019174002A1 (zh) * 2018-03-15 2019-09-19 江南大学 戊糖片球菌ccfm1012、其发酵食品及其在制备拮抗空肠弯曲杆菌感染药物中的应用
CN110384225A (zh) * 2018-04-16 2019-10-29 成都天卤八部食品有限公司 一种藿香味的香肠调料的制备方法
JP2021521863A (ja) * 2018-05-04 2021-08-30 セーホーエル．ハンセン アクティーゼルスカブ 硝酸レダクターゼ活性の回復改善
CN111676158B (zh) * 2020-06-08 2022-04-08 青岛玛斯特生物技术有限公司 一株乳酸片球菌及其在水产养殖中的应用
CN114437967B (zh) * 2022-01-06 2023-07-18 中国农业科学院农产品加工研究所 乳酸片球菌AUd2101及在制备治疗犬腹泻制剂中的应用
CN114874937B (zh) * 2022-04-30 2024-02-20 浙江工商大学 清酒乳杆菌产细菌素的分离纯化及抗菌用途和所用乳酸菌

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2051729C3 (de) * 1970-10-21 1975-01-30 Maizena Gmbh, 2000 Hamburg Trockenprodukt aus Wein
CA2043463A1 (en) 1990-06-13 1991-12-14 Nancy L. Bycroft Synergistic antimicrobial compositions
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5364645A (en) * 1992-10-30 1994-11-15 The Regents Of The University Of California Method of controlling microorganisms by pulsed ultraviolet laser radiation
DE4328368A1 (de) 1993-08-24 1995-03-02 Mueller Karl & Co Kg Verwendung von Bacteriocin erzeugende Mikroorganismen zum Reifen von Rohwurst
JP4926707B2 (ja) * 2003-08-22 2012-05-09 ダニスコ エイ／エス 封入化抗菌材料
CN102188034A (zh) 2010-03-03 2011-09-21 天津科技大学 一种用于食品的复合生物防腐保鲜剂

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
CA2976292C (en) 2021-08-31
US10952448B2 (en) 2021-03-23
CA2976292A1 (en) 2016-08-18
WO2016128508A1 (en) 2016-08-18
PL3256009T3 (pl) 2019-04-30
MX2017010064A (es) 2017-11-01
DK3256009T3 (en) 2018-11-12
CN107404913A (zh) 2017-11-28
US20190029279A1 (en) 2019-01-31
AU2016217830B2 (en) 2020-09-10
CN107404913B (zh) 2021-05-18
EP3256009A1 (de) 2017-12-20
AU2016217830A1 (en) 2017-07-13
ES2702769T3 (es) 2019-03-05

Similar Documents

Publication Publication Date Title
EP3256009B1 (de) Reduktion der konzentration von gramnegativen bakterien in einem fermentierten lebensmittelprodukt durch kombination von rotweinextrakt und einer kultur mit mindestens einem bakteriocin-produzierenden milchsäurebakterienstamm
Ben Said et al. Bioprotective culture: A new generation of food additives for the preservation of food quality and safety
Mladenović et al. Enterobacteriaceae in food safety with an emphasis on raw milk and meat
EP2132297B1 (de) Neuer milchsäurebakterienstamm und dessen verwendung zum schutz von lebensmittelprodukten
Nieto-Lozano et al. The effect of the pediocin PA-1 produced by Pediococcus acidilactici against Listeria monocytogenes and Clostridium perfringens in Spanish dry-fermented sausages and frankfurters
Kröckel The role of lactic acid bacteria in safety and flavour development of meat and meat products
Diez et al. Application of organic acid salts and high-pressure treatments to improve the preservation of blood sausage
Danielski et al. Carnobacterium maltaromaticum as bioprotective culture in vitro and in cooked ham
Gálvez et al. Food applications and regulation
Azevedo et al. Non meat-based alheiras–a safer novel trend?
Arbulu et al. Bioprotective Cultures and Bacteriocins for Food
Patel et al. Lactic acid bacteria (LAB) bacteriocins: An ecological and sustainable biopreservative approach to improve the safety and shelf-life of foods
CN101155910A (zh) 用于处理食物的乳酸细菌
CA3073143C (en) New lactobacillus curvatus strains useful for inhibition of listeria
Chikthimmah et al. Survival of Escherichia coli O157: H7, Salmonella Typhimurium, and Listeria monocytogenes in and on vacuum packaged Lebanon bologna stored at 3.6 and 13.0 C
Rovira et al. Protective cultures for the safety of animal-derived foods
Cegielska-Radziejewska et al. Quality and shelf life of chilled, pretreated MAP poultry meat products
Patel et al. Lactic Acid Bacteria (Lab) Bacteriocins: An Ecologicaland Sustainable Biopreservativeapproach to Improve The Safety and Shelf Life of Foods
DK2132297T3 (en) Hitherto unknown lactic acid bacterial strain and its use for the protection of food products
Marcelli et al. Research progress on the use of lactic acid bacteria as natural bio-preservatives against Pseudomonas spp. in meat and meat products: A review
Gaare et al. Potential Use of Lactic Acid Bacteria (LAB): Protective Cultures in Food Biopreservation
Drosinos et al. Biopreservation: A new direction towards food safety
Gálvez et al. Biopreservation of Meats and Meat Products
Campos et al. The use of bacteriocins against meat-borne pathogens
Tirloni Improvement of food safety and microbial interactions

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170911

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20180703

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1047651

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016006238

Country of ref document: DE

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20181106

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2702769

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20190305

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1047651

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181003

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190103

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190103

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190203

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190104

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190203

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016006238

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

26N No opposition filed

Effective date: 20190704

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190228

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20160211

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20211223

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20220209

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20220111

Year of fee payment: 7

Ref country code: ES

Payment date: 20220303

Year of fee payment: 7

Ref country code: CZ

Payment date: 20220118

Year of fee payment: 7

Ref country code: BE

Payment date: 20220118

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20221220

Year of fee payment: 8

Ref country code: IE

Payment date: 20221209

Year of fee payment: 8

Ref country code: FR

Payment date: 20221208

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20221213

Year of fee payment: 8

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20230228

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20230228

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20230211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230211

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230211

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230228

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20240405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230212

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231220

Year of fee payment: 9

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20240301